Photo of Paul Mullan
 

View Scopus Profile

Paul Mullan

Dr

  • Room 02.005 - CCRCB

    United Kingdom

Accepting PhD Students

PhD projects

Dr Mullan's group is open to wide-ranging PhD applications from candidates with a basic science or clinical background. His fields of interest include: - Molecular Oncology - Cancer Biology and Signal Transduction - Drug discovery and development - Biomarkers, diagnosis and early detection of cancer Previous research experience is desirable although not essential.

20002020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Paul Mullan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 56 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

R1944CNR: The identification and testing of blood markers to detect the presence of early ovarian stage cancers, speeding up patient diagnosis and ultimately improving patient survival.

Mullan, P. & Beirne, J. P.

06/09/2018 → …

Project: Research

R5771CNR: Establishment of an Integrated Almac-QUB Drug Discovery Unit at CCRCB

Waugh, D., Harkin, P., Johnston, P., Kennedy, R., Longley, D., Mullan, P., O'Sullivan, J., Prise, K., Salto-Tellez, M., Williams, R. & Wilson, R.

01/08/2012 → 30/04/2016

Project: Research

R1289CNR: Development of a Biomarker for the SRC Pathway in Ovarian Cancer

Kennedy, R. & Mullan, P.

01/08/2012 → 28/03/2015

Project: Research

R3511CNR: Establishment of an Integrated Almac-QUB Drug Discovery Unit at CCRCB

Harrison, T., Harkin, P., Johnston, P., Kennedy, R., Longley, D., Mullan, P., Prise, K., Salto-Tellez, M., Waugh, D., Williams, R. & Wilson, R.

01/08/2012 → 30/04/2016

Project: Research

Research Output

Development of a novel allograft model of prostate cancer: a new tool to inform clinical translation

Haughey, C. M., Mukherjee, D., Steele, R. E., Popple, A., Dura-Perez, L., Pickard, A., Jain, S., Mullan, P. B., Williams, R., Oliveira, P., Buckley, N. E., Honeychurch, J., Williams, R., McDade, S., Illidge, T., Mills, I. G. & Eddie, S. L., 2020

Research output: Other contribution

Open Access

    • Glucocorticoid Receptor Expression Predicts Good Outcome in response to Taxane-Free, Anthracycline-Based Therapy in Triple Negative Breast Cancer

    Elkashif, A., Bingham, V., Haddock, P., Humphries, M., McQuaid, S., Mullan, P., McCarthy, H. & Buckley, N. E., 20 May 2020, In : Journal of Oncology.

    Research output: Contribution to journal › Article

    Open Access
    File
    • 12 Downloads (Pure)

    Pin1 plays a key role in the response to treatment and clinical outcome in Triple Negative Breast Cancer

    Knowlson, C., Coulter, P., Bingham, V., McQuaid, S., Mullan, P. & Buckley, N. E., 09 Mar 2020, In : Therapeutic Advances in Medical Oncology.

    Research output: Contribution to journal › Article

    Open Access
    • 2 Citations (Scopus)

    Defining the molecular evolution of extrauterine high grade serous carcinoma

    Beirne, J. P., McArt, D. G., Roddy, A., McDermott, C., Ferris, J., Buckley, N. E., Coulter, P., McCabe, N., Eddie, S. L., Dunne, P. D., O'Reilly, P., Gilmore, A., Feeney, L., Ewing, D. L., Drapkin, R. I., Salto-Tellez, M., Kennedy, R. D., Harley, I. J. G., McCluggage, W. G. & Mullan, P. B., 04 Sep 2019, In : Gynecologic Oncology. 155, 2, p. 305-317 13 p.

    Research output: Contribution to journal › Article

    • 1 Citation (Scopus)

    Fibroblast-derived Gremlin1 localises to epithelial cells at the base of the intestinal crypt

    Dutton, L. R., Hoare, O. P., McCorry, A. M. B., Redmond, K. L., Adam, N. E., Canamara, S., Bingham, V., Mullan, P. B., Lawler, M., Dunne, P. D. & Brazil, D. P., 23 Jul 2019, In : Oncotarget. 10, 45, p. 4630-4639 10 p.

    Research output: Contribution to journal › Article

    Open Access
    File
    • 4 Citations (Scopus)
    124 Downloads (Pure)

    Impact

    Development and Commercialization of a Technology Platform to Enable Biomarker Discovery and Validation

    Richard Kennedy (Participant), Paul Harkin (Participant), Patrick Johnston (Participant), Alison Hosey (Participant), Julia Miskelly (Participant), Margaret Murray (Participant), Jennifer Quinn (Participant), Colin James (Participant), Jude Mulligan (Participant), Peter Daly (Participant), Paul Mullan (Participant), Julie Mussen (Participant), Ultan McDermott (Participant), Richard Wilson (Participant) & Daniel Longley (Participant)

    Impact: Health Impact, Quality of Life Impact

    Thesis

    Identifying Oncogenic Drivers of Poor Outcome in Triple Negative Breast Cancer

    Author: Beattie, S., Jul 2020

    Supervisor: Mullan, P. (Supervisor) & Buckley, N. (Supervisor)

    Student thesis: Doctoral Thesis › Doctor of Philosophy

    File

    The development of a blood-based test of DNA methylation for the earlier detection of high-grade serous tubo-ovarian cancer

    Author: Feeney, L., Jul 2020

    Supervisor: Mullan, P. (Supervisor), Salto-Tellez, M. (Supervisor) & Beirne, J. P. (Supervisor)

    Student thesis: Doctoral Thesis › Doctor of Philosophy